Bio-Cell Ltd

Avg. Two Year Performance

No purchase track record
74% Avg. Sale Return
32% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(1%)19%22%34%74%
Sale Success Rate0 of 11 of 11 of 11 of 11 of 1

Protalix BioTherapeutics, I...

Drugs » Biotechnology

10% Owner:

Holdings: 1.51M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--